History of ALS: decades of scant progress and unmet needs

IJMS, Free Full-Text

History of ALS: decades of scant progress and unmet needs

NORD Survey to Better Understand Rare Disease Diagnosis, Care and Treatment in the US: Take Part in Our 30 Year Follow-up - National Organization for Rare Disorders

NORD and the Galactosemia Foundation Jointly Publish First “Voice of the Patient” Report to Help Inform the FDA and Researchers - National Organization for Rare Disorders

What to know about the new ALS drug - The Washington Post

Supplementing Diet with Amino Acid Successfully Staves off Signs of ALS in Pre-Clinical Study - InventUM

Voltage-Induced Misfolding of Zinc-Replete ALS Mutant Superoxide Dismutase-1

Dystonia Nature Reviews Disease Primers

Pharmaceutics, Free Full-Text

Foods February-1 2022 - Browse Articles

Frontiers Common Fatal Neurodegenerative Diseases Revisited: Beyond Age, Comorbidities, and Devastating Terminal Neuropathology There Is Hope With Prevention